Biotech Values

[RNsidersbuying]

IPATF .511 - building a small position in this obscure penny-biotech. They actually have substantial growing revenue (recent filing) and most dilution seems to be through private-investors and at .80 cents?

I haven't looked at a pennystock in years until all this virus business. I'd sure like to hear some other opinions?

During the nine months ended January 31, 2020 the Company achieved revenues of $9,912,904, compared to revenues of $8,285,159 in the 2019 fiscal period.

https://backend.otcmarkets.com/otcapi/company/financial-report/241518/content